Document is current
Any future updates will be listed below
-
Authors
Mollan, Susan P. http://orcid.org/0000-0002-6314-4437
Lee, Andrew G.
Fraser, Clare L. http://orcid.org/0000-0002-0379-7743
- License Information
-
More Information
Article History
Received: 8 June 2024
Revised: 13 June 2024
Accepted: 17 June 2024
First Online: 26 June 2024
Competing interests
: SPM has received payment for consultancy work from Invex Therapeutics. She has received payment for advisory boards from Gentech and Ocular Therapeutix. Grant funding has been paid to her institution from the National Institute of Health Research (NIHR131211), UK Space Agency and IIHUK. She is also a member of the <i>Eye</i> editorial board. AGL, MD, is on the speaker’s bureau for Amgen and Alexion and the Advisory boards for Viridian and is a consultant for Astrazeneca, Bristol Myers Squibb, and Stoke Therapeutics. AGL is also a consultant for the National Football League, NASA, and the United States Department of Justice. AGL is also a member of the <i>Eye</i> editorial board. CLF received payment for the Invex Therapeutics trial steering committee.
Free to read: This content has been made available to all.
